Dominick Colangelo - 24 Feb 2026 Form 4 Insider Report for Vericel Corp (VCEL)

Role: President and CEO, Director
Signature: /s/ Sean Flynn, as Attorney-in-Fact for Dominick C. Colangelo
Issuer symbol: VCEL
Transactions as of: 24 Feb 2026
Net transactions value: -$336,106
Form type: 4
Filing time: 26 Feb 2026, 16:05:36 UTC
Previous filing: 20 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Colangelo Dominick	President and CEO, Director	64 SIDNEY STREET, CAMBRIDGE	/s/ Sean Flynn, as Attorney-in-Fact for Dominick C. Colangelo	26 Feb 2026	0001313403

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VCEL	Common Stock	Options Exercise		+18,250	+6.4%		303,020	24 Feb 2026	Direct	F1, F2, F3
transaction	VCEL	Common Stock	Options Exercise	$0	+18,250	+6%	$0.000000	321,270	24 Feb 2026	Direct	F3, F4
transaction	VCEL	Common Stock	Tax liability	$336,106	-8,824	-2.7%	$38.09	312,446	24 Feb 2026	Direct	F3, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCEL	Restricted Stock Unit	Options Exercise		+18,250	+100%		36,500	24 Feb 2026	Common Stock	18,250		Direct	F2, F6, F7
transaction	VCEL	Restricted Stock Unit	Options Exercise		+18,250	+50%		54,750	24 Feb 2026	Common Stock	18,250		Direct	F4, F6, F7, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units (RSUs) converted to phantom stock units and are deferred under the Vericel Corporation Deferred Compensation Plan. The units will be payable only in shares of Common Stock upon the Reporting Person's elected Benefit Distribution Date.
F2	The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 22, 2024. The remaining RSUs will vest on February 22, 2027, and February 22, 2028, respectively. Upon the vesting of RSUs granted to the Reporting Person on February 22, 2024, the Reporting Person deferred the receipt of 18,250 shares of Common Stock and instead received 18,250 shares of Phantom Stock pursuant to the Vericel Corporation Deferred Compensation Plan.
F3	These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F4	The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on February 20, 2025. The remaining RSUs will vest on February 20, 2027, February 20, 2028, and February 20, 2029, respectively.
F5	These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs.
F6	Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
F7	No expiration date for this type of award.
F8	The Fair Market Value of the vested derivative securities is $38.09 per share.